editor
note
editori
publish
onlin
preprint
proof
februari
prior
number
clinic
scientif
develop
surround
fastmov
diseas
reader
seek
current
inform
diagnosi
treatment
prevent
decemb
wuhan
hubei
provinc
china
one
six
megalopolis
popul
million
becam
center
outbreak
pneumonia
unknown
caus
earli
case
link
huanan
seafood
market
market
shut
januari
one
week
later
januari
chines
health
author
confirm
identifi
novel
coronaviru
chines
center
diseas
control
prevent
issu
epidem
updat
risk
assess
late
januari
document
describ
evid
regard
known
caus
pathogen
epidemiolog
clinic
featur
ill
diagnosi
manag
essenti
public
prevent
measur
chines
center
diseas
control
prevent
provid
practic
guidanc
public
protect
infect
includ
recommend
issu
januari
travel
avoid
nonessenti
travel
china
within
month
detect
incid
case
sever
chines
scientist
isol
viru
sequenc
fulllength
genom
describ
specif
morpholog
initi
genom
sequenc
share
world
health
organ
januari
sever
investig
team
independ
isol
character
viral
genom
sequenc
made
publicli
avail
global
initi
share
influenza
data
platform
http
wwwgisaidorg
infect
patient
also
confirm
use
cell
entri
receptor
angiotensinconvert
enzym
sarscov
highli
express
airway
epitheli
cell
zhu
et
al
also
identifi
character
report
isol
viru
provid
initi
descript
specif
cytopath
effect
morpholog
seem
seventh
member
famili
coronavirus
infect
human
notabl
grew
readili
primari
human
airway
epitheli
cell
standard
tissu
cultur
cell
unlik
sarscov
merscov
suggest
potenti
increas
infect
homolog
model
reveal
amino
acid
variat
key
residu
benchmark
sarscov
clear
whether
chang
lead
facilit
viru
infect
inform
produc
research
allow
medic
scientif
commun
better
understand
transmiss
develop
rapid
diagnost
test
effici
epidemiolog
control
facilit
develop
antivir
therapi
vaccin
ren
et
al
report
clinic
manifest
infect
caus
novel
batorigin
humaninfect
coronaviru
includ
potenti
lethal
januari
huang
et
al
report
lancet
epidemiolog
clinic
laboratori
radiolog
characterist
well
treatment
outcom
viru
understand
clinic
featur
help
clinician
recogn
infect
patient
minim
risk
exposur
other
infer
target
cell
might
lower
airway
due
featur
present
lack
promin
upper
respiratori
tract
sign
symptom
groundglass
opac
chest
ct
imag
older
male
subject
comorbid
report
sever
even
fatal
respiratori
diseas
addit
studi
help
assess
host
risk
factor
diseas
sever
mortal
laboratori
evalu
found
lymphopenia
patient
cytokin
storm
profil
critic
ill
combin
viral
replic
lower
respiratori
tract
aberr
immun
respons
may
impact
sever
ill
similar
proven
sar
mer
translat
research
may
discov
biomark
cofactor
trigger
infect
patient
differ
risk
stratif
famili
cluster
pneumonia
due
report
find
consist
persontoperson
transmiss
highlight
risk
spread
support
report
infect
travel
geograph
region
last
week
januari
thirteen
children
diagnos
fortun
mild
clinic
present
inform
suggest
possibl
coronaviru
transmiss
evolv
basic
reproduct
number
estim
lower
sarscov
around
howev
host
viru
interact
may
hasten
birth
potenti
super
spreader
lead
major
outbreak
due
sever
lung
injuri
caus
sarscov
merscov
patient
infect
requir
invas
mechan
ventil
extracorpor
membran
oxygen
high
mortal
unfortun
specif
coronaviru
antivir
agent
vaccin
proven
effect
histor
control
studi
combin
proteas
inhibitor
lopinavir
ritonavir
associ
substanti
clinic
benefit
among
patient
sarscov
result
vitro
cell
vivo
anim
studi
suggest
combin
lopinavirritonavir
may
effect
merscov
placebocontrol
trial
lopinavirritonavir
initi
patient
laboratoryconfirm
mer
requir
hospit
admiss
saudi
arabia
remdesivir
cyanosubstitut
adenosin
nucleotid
analogu
prodrug
broadspectrum
antivir
activ
sever
rna
virus
may
evalu
first
report
patient
infect
unit
state
administ
remdesivir
base
worsen
clinic
statu
iv
remdesivir
given
compassion
use
hospit
day
ill
day
two
random
control
trial
regist
evalu
safeti
efficaci
remdesivir
mild
moder
sever
patient
viral
pneumonia
kirchdoerf
ward
notic
nonstructur
protein
nsp
polymeras
may
templat
design
novel
antivir
therapeut
agent
interrupt
assembl
sarscov
core
rnasynthesi
machineri
fulllength
genom
sequenc
nucleotid
ident
sarscov
allow
molecular
editori
structur
inform
use
model
coronaviru
antivir
design
clinic
studi
assess
effect
safeti
monoclon
polyclon
neutral
antibodi
product
aim
discov
therapeut
target
immunopatholog
host
respons
china
establish
effect
detect
network
respons
outbreak
infecti
diseas
sar
pandem
great
signific
share
known
genom
sequenc
epidemiolog
clinic
featur
ill
social
media
era
epidem
occur
great
deal
misinform
readili
avail
hope
earli
suggest
infect
lower
lethal
sar
hold
true
contrast
low
health
threat
individu
level
mean
potenti
caus
disrupt
global
public
health
system
long
durat
persontoperson
transmiss
mild
ill
asymptomat
carrier
may
potenti
sourc
infect
sustain
local
epidem
global
spread
reduc
panic
econom
loss
manag
save
infect
much
remain
done
goal
break
transmiss
chain
requir
effect
program
trace
diagnos
cure
everi
infect
patient
need
awar
risk
anoth
zoonot
viru
cross
speci
infect
human
popul
futur
great
imper
call
global
action
deal
major
public
health
emerg
